FDA Approved: DAWNZERA — Original Application (Ionis Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Dawnzera (donidalorsen) from Ionis Pharmaceuticals as an original new drug for the prevention of hereditary angioedema attacks. It represents I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• DAWNZERA (DONIDALORSEN)

Snippet

ORIG AP for DAWNZERA (DONIDALORSEN)